Pay in 4 interest-free payments of $5.07 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
Quick Stats of the GLP-1 Nutritional Support Market Industry Value (2025): USD 4.1 billion Forecast Value (2035): USD 13 billion Global CAGR (2025 to 2035): 12.2% Leading Segment in 2025: Protein & Macronutrient Blends (~43% share) Key Growth Region: East Asia Key Players: Nestl Health Science, Abbott, Herbalife, Unjury Protein, ProCare Health, Expansion is being shaped by clinical treatment protocols and broader reimbursement for weight loss and metabolic support
Some other options that are growing in popularity are tesamorelin, thymosin beta-4, and the focus of this guide BPC-157
The combined therapy with liraglutide and metformin (COMBI) seems to be more effective
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist, a class of drugs that helps regulate blood sugar levels by increasing insulin secretion and decreasing the production of glucose in the liver
Benefits for some neurologic conditions, addictive behaviors and substance use disorders are being explored
